| author name | recommending | commenting | favorite | papers | recom. | cited | |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 215 | 0 | 2833 | [Update] | |
| 0 | 0 | 0 | 13 | 0 | 57 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 59 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 7 | 0 | 2 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 3 | [Update] | |
| 0 | 0 | 0 | 2 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 3 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 22 | 0 | 126 | [Update] | |
| 0 | 0 | 0 | 8 | 0 | 5 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 2 | 0 | 12 | [Update] | |
| 0 | 0 | 0 | 6 | 0 | 20 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 2 | [Update] | |
| 0 | 0 | 0 | 2 | 0 | 0 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 3 | [Update] | |
| 0 | 0 | 0 | 1 | 0 | 10 | [Update] | |
| 0 | 0 | 0 | 23 | 0 | 60 | [Update] | |
| 0 | 0 | 0 | 2 | 0 | 3 | [Update] |
Latest Paper:
David C Blakemore,
Justin S Bryans,
Pauline Carnell,
Mark J Field,
Natasha Kinsella,
Jack K Kinsora,
Leonard T Meltzer,
Simon A Osborne,
Lisa R Thompson,
Sophie C Williams
Sandwich Laboratories, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK.
A range of 3,4-alkylated five-membered ring derivatives of gabapentin were synthesised. One compound (21) had an excellent level of potency against alpha(2)delta and was profiled in in vivo models of pain and anxiety.
David C Blakemore,
Justin S Bryans,
Pauline Carnell,
Nicola E A Chessum,
Mark J Field,
Natasha Kinsella,
Jack K Kinsora,
Simon A Osborne,
Sophie C Williams
Sandwich Laboratories, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK.
A range of 3-alkylated five-membered ring derivatives of Gabapentin were synthesized and several were found to have good levels of potency against the alpha2delta calcium subunit of a voltage-gated calcium channel. Two compounds were profiled in in vivo models of pain and anxiety.
Marc T Abrams,
Martin L Koser,
Jessica Seitzer,
Stephanie C Williams,
Martha A Dipietro,
Weimin Wang,
Andrew W Shaw,
Xianzhi Mao,
Vasant Jadhav,
Joseph P Davide,
Paul A Burke,
Alan B Sachs,
Steven M Stirdivant,
Laura Sepp-Lorenzino
Department of RNA Therapeutics, Merck and Co., Inc, West Point, Pennsylvania, USA.
Despite recent progress, systemic delivery remains the major hurdle for development of safe and effective small inhibitory RNA (siRNA)-based therapeutics. Encapsulation of siRNA into liposomes is a promising option to overcome obstacles such as low stability in serum and inefficient internalization by target cells. However, a major liability of liposomes is the potential to induce an acute inflammatory response, thereby increasing the risk of numerous adverse effects. In this study, we characterized a liposomal siRNA delivery vehicle, LNP201, which is capable of silencing an mRNA target in mouse liver by over 80%. The biodistribution profile, efficacy after single and multiple doses, mechanism of action, and inflammatory toxicity are characterized for LNP201. Furthermore, we demonstrate that the glucocorticoid receptor (GR) agonist dexamethasone (Dex) inhibits LNP201-induced cytokine release, inflammatory gene induction, and mitogen-activated protein kinase (MAPK) phosphorylation in multiple tissues. These data present a possible clinical strategy for increasing the safety profile of siRNA-based drugs while maintaining the potency of gene silencing.
Paul Allen,
Klaas E Stephan,
Andrea Mechelli,
Fern Day,
Nicholas Ward,
Jeffery Dalton,
Steven C Williams,
Philip McGuire
Division of Psychological Medicine, Institute of Psychiatry, King's College London, UK.
Schizophrenia is associated with fronto-temporal dysconnectivity, but it is not clear whether this is a risk factor for the disorder or is a consequence of the established illness. The aim of the present study was to use fMRI to investigate fronto-temporal connectivity in subjects with prodromal signs of schizophrenia using the Hayling sentence completion task (HSCT). Thirty participants, 15 with an At Risk Mental State (ARMS) and 15 Healthy Controls were scanned whilst completing 80 sentence stems. The congruency and constraint of sentences varied across trials. Dynamic Causal Modelling (DCM) and Bayesian Model Selection (BMS) were used to compare alternative models of connectivity in a task related network. During the HSCT ARMS subjects did not differ from Healthy Controls in terms of fronto-temporal activation, i.e. there was neither a main effect of group nor a group-by-task interaction. However, there was both a significant main effect of group and a significant interaction in the anterior cingulate cortex (ACC), with greater ACC activity in the ARMS subjects. A systematic BMS procedure among 14 alternative DCMs including the ACC, middle frontal and middle temporal gyri revealed intact task dependent modulation of fronto-temporal effective connectivity in the ARMS group. However, ARMS subjects showed increased endogenous connection strength between the ACC and the middle temporal gyrus relative to Healthy Controls. Although task related fronto-temporal integration in the ARMS was intact, this may depend on increased engagement of the ACC which was not observed in Healthy Control subjects.
Scott C Williams,
Joanne M Hafner,
David J Morton,
Amanda L Holm,
Sharon M Milberger,
Richard G Koss,
Jerod M Loeb
The Joint Commission, United States;
BACKGROUND: The adoption of a smoke-free hospital campus policy is often a highly publicized local event. National media coverage suggests that the trend toward adopting these policies is growing, and this publicity can frequently lead hospital administrators to consider the adoption of such policies within their own institutions. Little is actually known, however, about the prevalence of these policies or their impact. OBJECTIVES: To determine the national prevalence of smoke-free hospital campus policies and the relationship between these policies and performance on nationally-standardized measures for smoking cessation counseling in U.S. hospitals. METHODS: 4,494 Joint Commission-accredited hospitals were invited to complete a web-based questionnaire assessing current smoking policies and future plans. Smoking cessation counseling rates were assessed through nationally-standardized measures. RESULTS: The 1,916 hospitals responding to the survey (43%) were statistically similar to non-responders with respect to performance measure rates, smoking policies, and demographic characteristics. Approximately 45% of responders reported an existing smoke-free hospital campus policy. With respect to demographics, higher proportions of smoke-free campus policies were reported in non-teaching and non-profit hospitals. Smoke-free campus hospitals were also more likely to provide smoking cessation counseling to acute myocardial infarction, heart failure, and pneumonia patients who smoke (p< .001). CONCLUSIONS: By February 2008, 45% of U.S. hospitals (up from approximately 3% in 1992) had adopted a smoke-free campus policy; another 15% reported actively pursuing the adoption of such a policy. By the end of 2009, it is likely that the majority of U.S. hospitals will have a smoke-free campus.
The Connecticut Agricultural Experiment Station, Department of Forestry and Horticulture, PO Box 1106, New Haven, CT 06504, USA. scott.williams@po.state.ct.us.
In many Connecticut forests with an overabundance of white-tailed deer (Odocoileus virginianus Zimmermann), Japanese barberry (Berberis thunbergii DC) has become the dominant understory shrub, which may provide a habitat favorable to blacklegged tick (Ixodes scapularis Say) and white-footed mouse (Peromyscus leucopus Rafinesque) survival. To determine mouse and larval tick abundances at three replicate sites over 2 yr, mice were trapped in unmanipulated dense barberry infestations, areas where barberry was controlled, and areas where barberry was absent. The number of feeding larval ticks/mouse was recorded. Adult and nymphal ticks were sampled along 200-m draglines in each treatment, retained, and were tested for Borrelia burgdorferi (Johnson, Schmid, Hyde, Steigerwalt, and Brenner) presence. Total first-captured mouse counts did not differ between treatments. Mean number of feeding larval ticks per mouse was highest on mice captured in dense barberry. Adult tick densities in dense barberry were higher than in both controlled barberry and no barberry areas. Ticks sampled from full barberry infestations and controlled barberry areas had similar infection prevalence with B. burgdorferi the first year. In areas where barberry was controlled, infection prevalence was reduced to equal that of no barberry areas the second year of the study. Results indicate that managing Japanese barberry will have a positive effect on public health by reducing the number of B. burgdorferi-infected blacklegged ticks that can develop into motile life stages that commonly feed on humans.
P Fusar-Poli,
M R Broome,
P Matthiasson,
J B Woolley,
A Mechelli,
L C Johns,
P Tabraham,
E Bramon,
L Valmaggia,
S C Williams,
P McGuire
2Section of Neuroimaging, Division of Psychological Medicine, Institute of Psychiatry, King's College London, London, UK.
Background: The prodromal phase of psychosis is characterized by impaired executive function and altered prefrontal activation. The extent to which the severity of these deficits at presentation predicts subsequent clinical outcomes is unclear. Methods: We employed functional magnetic resonance imaging in a cohort of subjects at clinical risk for psychosis and in healthy controls. Images were acquired at clinical presentation and again after 1 year, using a 1.5-T Signa MRI scanner while subjects were performing a verbal fluency task. SPM5 was used for the analysis of imaging data. Psychopathological assessment of the "at-risk" symptoms was performed by using the Comprehensive Assessment for the At-Risk Mental State (CAARMS) and the Positive and Negative Symptom Scale (PANSS). Results: In the at-risk mental state (ARMS) group, between presentation and follow-up, the CAARMS (perceptual disorder and thought disorder subscales) and the PANSS general scores decreased, while the Global Assessment of Functioning (GAF) score increased. Both the ARMS and control groups performed the verbal fluency task with a high degree of accuracy. The ARMS group showed greater activation in the left inferior frontal gyrus but less activation in the anterior cingulate gyrus than controls. Within the ARMS group, the longitudinal normalization of neurofunctional response in the left inferior frontal gyrus was positively correlated with the improvement in severity of hallucination-like experiences. Conclusions: The normalization of the abnormal prefrontal response during executive functioning is associated with 12-month psychopathological improvement of prodromal symptoms.
Hiromasa Funato,
Allen L Tsai,
Jon T Willie,
Yasushi Kisanuki,
S Clay Williams,
Takeshi Sakurai,
Masashi Yanagisawa
Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.
The hypothalamic orexin neuropeptide acutely promotes appetite, yet orexin deficiency in humans and mice is associated with obesity. Prolonged effects of increased orexin signaling upon energy homeostasis have not been fully characterized. Here, we examine the metabolic effects of orexin gain of function utilizing genetic and pharmacologic techniques in mice. Transgenic orexin overexpression confers resistance to high-fat diet-induced obesity and insulin insensitivity by promoting energy expenditure and reducing consumption. Genetic studies indicate that orexin receptor-2 (OX2R), rather than OX1R signaling, predominantly mediates this phenotype. Likewise, prolonged central administration of an OX2R-selective peptide agonist inhibits diet-induced obesity. While orexin overexpression enhances the anorectic-catabolic effects of central leptin administration, obese leptin-deficient mice are completely resistant to the metabolic effects of orexin overexpression or OX2R agonist infusion. We conclude that enhanced orexin-OX2R signaling confers resistance to diet-induced features of the metabolic syndrome through negative energy homeostasis and improved leptin sensitivity.
Buck S Samuel,
Abdullah Shaito,
Toshiyuki Motoike,
Federico E Rey,
Fredrik Backhed,
Jill K Manchester,
Robert E Hammer,
S Clay Williams,
Jan Crowley,
Masashi Yanagisawa,
Jeffrey I Gordon
Center for Genome Sciences and.
The distal human intestine harbors trillions of microbes that allow us to extract calories from otherwise indigestible dietary polysaccharides. The products of polysaccharide fermentation include short-chain fatty acids that are ligands for Gpr41, a G protein-coupled receptor expressed by a subset of enteroendocrine cells in the gut epithelium. To examine the contribution of Gpr41 to energy balance, we compared Gpr41-/- and Gpr41+/+ mice that were either conventionally-raised with a complete gut microbiota or were reared germ-free and then cocolonized as young adults with two prominent members of the human distal gut microbial community: the saccharolytic bacterium, Bacteroides thetaiotaomicron and the methanogenic archaeon, Methanobrevibacter smithii. Both conventionally-raised and gnotobiotic Gpr41-/- mice colonized with the model fermentative community are significantly leaner and weigh less than their WT (+/+) littermates, despite similar levels of chow consumption. These differences are not evident when germ-free WT and germ-free Gpr41 knockout animals are compared. Functional genomic, biochemical, and physiologic studies of germ-free and cocolonized Gpr41-/- and +/+ littermates disclosed that Gpr41-deficiency is associated with reduced expression of PYY, an enteroendocrine cell-derived hormone that normally inhibits gut motility, increased intestinal transit rate, and reduced harvest of energy (short-chain fatty acids) from the diet. These results reveal that Gpr41 is a regulator of host energy balance through effects that are dependent upon the gut microbiota.
Department of Clinical Neuroscience, King's College London, London, UK; Department of Neuroscience, Institute of Psychiatry, King's College London, London, UK.
Non-invasive identification of transplanted neural stem cells in vivo by pre-labelling with contrast agents may play an important role in the translation of cell therapy to the clinic. Understanding the impact of these labels on the cells' ability to repair is therefore vital. In rats with middle cerebral artery occlusion (MCAo), a model of stroke, the transhemispheric migration of MHP36 cells labelled with the bimodal contrast agent GRID was detected on magnetic resonance images (MRI) up to 4 weeks following transplantation. However, compared to MHP36 cells labelled with the red fluorescent dye PKH26, GRID-labelled transplants did not significantly improve behaviour, and performance was akin to non-treated animals. Likewise, the evolution of anatomical damage as assessed by serial, T(2)-weighted MRI over 1 year indicated that GRID-labelled transplants resulted in a slight increase in lesion size compared to MCAo-only animals, whereas the same, PKH26-labelled cells significantly decreased lesion size by 35%. Although GRID labelling allows the in vivo identification of transplanted cells up to 1 month after transplantation, it is likely that some is gradually degraded inside cells. The translation of cellular imaging therefore does not only require the in vitro assessment of contrast agents on cellular functions, but also requires the chronic, in vivo assessment of the label on the stem cells' ability to repair in preclinical models of neurological disease.
